scispace - formally typeset
K

Kevin A. Carter

Researcher at State University of New York System

Publications -  33
Citations -  1832

Kevin A. Carter is an academic researcher from State University of New York System. The author has contributed to research in topics: Liposome & Drug delivery. The author has an hindex of 19, co-authored 33 publications receiving 1402 citations. Previous affiliations of Kevin A. Carter include United States Naval Research Laboratory & University at Buffalo.

Papers
More filters
Journal ArticleDOI

Chemophototherapy: An Emerging Treatment Option for Solid Tumors.

TL;DR: Near infrared (NIR) light penetrates human tissues with limited depth, thereby providing a method to safely deliver non‐ionizing radiation to well‐defined target tissue volumes and improving drug bioavailability with superior efficacy.
Journal ArticleDOI

Porphyrin–phospholipid liposomes permeabilized by near-infrared light

TL;DR: Liposomes doped with porphyrin–phospholipid that are permeabilized directly by near-infrared light are described and spatial and temporal control of release of entrapped fluorophores following intratumoral injection are demonstrated.
Journal ArticleDOI

Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release

TL;DR: Dox-loaded stealth PoP liposomes represent the first reported long-circulating nanoparticle capable of light-triggered drug release, and are used to extend the blood circulation time of encapsulated therapeutics.
Journal ArticleDOI

Rapid Light-Triggered Drug Release in Liposomes Containing Small Amounts of Unsaturated and Porphyrin-Phospholipids.

TL;DR: Human pancreatic xenograft growth in mice is significantly delayed with a single chemophototherapy treatment following intravenous administration of 6 mg kg(-1) doxorubicin, loaded in liposomes containing small amounts of DOPC and PoP.
Journal ArticleDOI

A malaria vaccine adjuvant based on recombinant antigen binding to liposomes.

TL;DR: It is shown that recombinant, polyhistidine-tagged (his- tagged) Pfs25 can be mixed at the time of immunization with pre-formed liposomes containing cobalt porphyrin–phospholipid, resulting in spontaneous nanoliposome antigen particleization (SNAP).